Thyrotropin releasing hormone (TRH) selectively binds and activates the melanocortin 1 receptor

Peptides

Volumn 20, Issue 3, 1999, Pages 395-400

  Schiöth, Helgi B ^a   Prusis, Peteris ^a   Muceniece, Ruta ^a,b   Mutulis, Felikss ^a,b   Mutule, Ilze ^a,b   Wikberg, Jarl E S ^a  

^a UPPSALA UNIVERSITY   (Sweden)

^b LATVIAN INSTITUTE OF ORGANIC SYNTHESIS   (Latvia)

Author keywords

cAMP; Ligand binding; Melanocortin (MC) receptor subtypes; MSH (melanocyte stimulating hormone); TRH

Indexed keywords

CYCLIC AMP; MELANOCORTIN; MELANOCORTIN RECEPTOR; PROTIRELIN; PROTIRELIN DERIVATIVE; RECEPTOR SUBTYPE;

AMINO ACID COMPOSITION; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CONTROLLED STUDY; DRUG RECEPTOR BINDING; GENE EXPRESSION; HUMAN; IN VITRO STUDY; MELANOMA B16; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION;

ANIMALS; BINDING SITES; COS CELLS; HUMANS; LIGANDS; RECEPTORS, CORTICOTROPIN; RECEPTORS, MELANOCORTIN; SIGNAL TRANSDUCTION; THYROTROPIN-RELEASING HORMONE; TRANSFECTION; TUMOR CELLS, CULTURED;

EID: 0344117854     PISSN: 01969781     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0196-9781(98)00168-5     Document Type: Article

References (31)

1. Allen F.H., Kennard O. 3D search and research using the Cambridge Structural database. Chemical Design Automation News. 8:1993;31-37.
2. Brünger AT. X-PLOR Version 3.1. A system for X-ray crystallography and NMR. New Haven and London: Yale University Press; 1992.
3. Brooks R.B., Bruccoleri E.R., Olafson D.B., States J.D., Swaminathan S., Karplus M. CHARMM A program for macro-molecular energy minimization, and dynamics calculations . J Comput Chem. 4:1983;187-217.
4. Chen W., Kelly M.A., Opitz-Araya X., Thomas R.E., Low M.J., Cone R.D. Exocrine gland dysfunction in MC5-R-deficient mice evidence for coordinated regulation of exocrine gland function by melanocortin peptides . Cell. 91:1997;789-798.
5. Chhajlani V., Muceniece R., Wikberg J.E.S. Molecular cloning of a novel human melanocortin receptor. Biochem Biophys Res Commun. 195:1993;866-873.
6. Chhajlani V., Wikberg J.E.S. Molecular cloning and expression of the human melanocyte stimulating hormone receptor cDNA. FEBS Lett. 309:1992;417-420.
7. Eberle AN. The melanotropins in chemistry, physiology and mechanisms of action. Basel: S. Karger; 1988.
8. Gantz I., Konda Y., Tashiro T., Shimoto Y., Miwa H., Munzert G., Watson S.J., DelValle J., Yamada T. Molecular cloning of a novel melanocortin receptor. J Biol Chem. 268:1993;8246-8250.
9. Gantz I., Miwa H., Konda Y., Shimoto Y., Tashiro T., Watson S.J., DelValle J., Yamada T. Molecular cloning, expression, and gene localization of a fourth melanocortin receptor. J Biol Chem. 268:1993;15174-15179.
10. Gershengorn M.C., Osman R. Molecular and cellular biology of thyrotropin-releasing hormone receptors. Physiol Rev. 76:1996;175-191.
11. Huszar D., Lynch C.A., Fairchild-Huntress V., Dunmore J.H., Fang Q., Berkemeier L.R., Gu W., Kesterson R.A., Boston B.A., Cone R.D., Smith F.J., Campfield L.A., Burn P., Lee F. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell. 88:1997;131-141.
12. Kamiya K., Takamoto M., Wada Y., Fujino M., Nishikawa M. Molecular conformation of thyrotropin-releasin hormone from the X-ray structural analysis of its tartrate. J Chem Soc Chem Commun. 10:1980;438-439.
13. Kraulis J.P. MOLSCRIPT. A program to produce both detailed and schematic plots of protein structures. J Appl Crystallogr. 24:1991;946-950.
14. Lamacz M., Tonon M.C., Danger J.M., Jenks B., Kupryszewski G., Vaudry H. Biphasic effect of thyrotropin-releasing factor (TRH) on alpha-melanotropin secretion from frog intermediate lobe in vitro. Mol Cell Endocrinol. 50:1987;203-209.
15. Lamers A.E., Balm P.H., Haenen H.E., Jenks B.G., Wendelaar Bonga S.E. Regulation of differential release of alpha-melanocyte-stimulating hormone forms from the pituitary of a teleost fish, Oreochromis mossambicus. J Endocrinol. 129:1991;179-187.
16. Lipton J.M., Catania A. Anti-inflammatory actions of the neuroimmunomodulator alpha-MSH. Immunol. Today. 18:1997;140-145.
17. Mountjoy K.G., Robbins L.S., Mortrud M.T., Cone R.D. The cloning of a family of genes that encode the melanocortin receptors. Science. 257:1992;1248-1251.
18. Mountjoy K.G., Mortrud M.T., Low M.J., Simerly R.B., Cone R.D. Localization of the melanocortin-4 receptor (MC4-R) in endocrine and autonomic control circuits in the brain. Mol Endocrinol. 8:1994;1298-1308.
19. Neria E., Fisher S., Karplus M. Simulation of activation free-energies in molecular-systems. J Chem Phys. 105:1996;1902-1921.
20. Nordstedt C., Fredholm B.B. A modification of a protein-binding method for rapid quantification of cAMP in cell-culture supernatants and body fluid. Analytical Chem. 189:1990;231-234.
21. Prusis P, Schiöth HB, Muceniece R, Herzyk P, Afshar M, Hubbard RE, Wikberg JES. Modelling of the three-dimensional structure of the human melanocortin 1 receptor, using an automatic method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide J Mol Graphics and Mod 1998 In press.
22. Roselli-Rehfuss L., Mountjoy K.G., Robbins L.S., Mortrud M.T., Low M.J., Tatro J.B., Entwistle M.L., Simerly R.B., Cone R.D. Identification of a receptor for gamma melanotropin and other proopiomelanocortin peptides in the hypothalamus and limbic system. Proc Natl Acad Sci USA. 90:1993;8856-8860.
23. Schiöth H.B., Chhajlani V., Muceniece R., Klusa V., Wikberg J.E.S. Major pharmacological distinction of the ACTH receptor from the other melanocortic receptors. Life Sci. 59:1996;797-801.
24. Schiöth H.B., Muceniece R., Larsson M., Mutulis F., Szardenings M., Prusis P., Lindeberg G., Wikberg J.E.S. Binding of cyclic and linear MSH core peptides to the melanocortin receptor subtypes. Eur J Pharmacol. 319:1997;369-373.
25. 7] substituted MSH analogues for the melanocortin receptors. Peptides. 18:1997;1009-1013.
26. Schiöth H.B., Muceniece R., Wikberg J.E.S. Characterization of melanocortin 4 receptor by radioligand binding analysis. Pharmacol Toxicol. 79:1996;161-165.
27. Schiöth H.B., Muceniece R., Szardenings M., Prusis P., Wikberg J.E.S. Evidence indicating that the TM4, EL2 and TM5 of the melanocortin 3 receptor do not participate in ligand binding. Biochem Biophys Res Commun. 229:1996;687-692.
28. Schiöth H.B., Muceniece R., Wikberg J.E.S., Chhajlani V. Characterization of melanocortin receptor subtypes by radioligand binding analysis. Eur J Pharmacol Mol Pharm Sect. 288:1995;311-317.
29. Schiöth H.B., Yook P., Muceniece R., Prusis P., Wikberg J.E.S., Szardenings M. Chimeric melanocortin 1/3 receptors; Identification of domains determining the binding specificity of MSH peptides. Mol Pharmacol. 54:1998;154-161.
30. Siegrist W., Solca F., Stutz S., Giuffre L., Carrel S., Girard F., Eberle A.N. Characterization of receptors for α-melanocyte-stimulating hormone on human melanoma cells. Cancer Res. 49:1989;6352-6358.
31. Simpson E.R., Waterman M.R. Regulation of the synthesis of steroidogenic enzymes in adrenal cortical cells by ACTH. Ann Rev Physiol. 50:1988;427-440.